Where does Anovent Pharmaceutical (U.S.), LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Anovent Pharmaceutical (U.S.), LLC ranks #44,735 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Anovent Pharmaceutical (U.S.), LLC hold?

Anovent Pharmaceutical (U.S.), LLC holds 5 US utility patents granted between 2022 and 2023, spanning 6 technology areas.

What is Anovent Pharmaceutical (U.S.), LLC's Innovation Score?

Anovent Pharmaceutical (U.S.), LLC has an Innovation Score of 44.1 out of 100 (top 26% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Anovent Pharmaceutical (U.S.), LLC's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Anovent Pharmaceutical (U.S.), LLC.

What does claim depth mean for Anovent Pharmaceutical (U.S.), LLC's patents?

Anovent Pharmaceutical (U.S.), LLC's patents average 15.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Anovent Pharmaceutical (U.S.), LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Anovent Pharmaceutical (U.S.), LLC

Q: What technology areas does Anovent Pharmaceutical (U.S.), LLC focus on?

Anovent Pharmaceutical (U.S.), LLC's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 5 patents. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 6 technology areas, recorded in grant years 2022–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Anovent ranks #44,735 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 6 technology areas.

#44,735
of 49,997 US assignees by volume: Top 26%
by Innovation Score (44.1/100): 15.4
avg claims per patent

USPTO PatentsView assignee plate

Corpus R44735 · US Corporation #44,735 · 5 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
LOWER-Q #44,735/49,997
PHOTO-FINISH Anhui Maoxin Home…
CPC-NARROW A61K · 6 areas
INNOV-PAR 44.1/100
CLAIMS-RICH 15.4 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2022–2023 · 2y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Anhui Maoxin Home Crafts Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Aurigene Discovery · near

44
PAX Labs · near

44
Siemens Logistics · near

44
Tokai Optical · near

44
Anovent Pharmaceutic… · this assignee

44
3D Lighting… · lowest

7

What this shows Anovent's Innovation Score is 44.1/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Anovent's grants concentrate

Anovent Pharmaceutical (U.S.), LLC is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2022 (4 grants) versus a trough of 1 in 2023. By volume, Anovent sits between Anhui Maoxin Home Crafts Co., Ltd. and Antenna Company.

Anovent's three-year grant acceleration

Anovent Pharmaceutical (U.S.), LLC shows 5 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Anhui Maoxin Home…

5
Anixa Diagnostics

5
Ankom Technology

5
Anomera

5
Anqing Medical

5
Ansaldo Energia S…

5
Antares Vision S…

5
Antenna

5
Anovent Pharmaceu… ◀

5

What this shows Anovent holds 5 patents at rank #44,560, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Anovent

By rank, the assignees closest to #44,560 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Anovent's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Anovent, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (44 here).

Tokai Optical Co., Ltd. 44 Siemens Logistics GmbH 44 Aurigene Discovery Technologies Limited 44 PAX Labs, Inc. 44

Anovent's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 26% higher than 74% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table

Anovent Pharmaceutical (U.S.), LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2022	4	80.0%
2023	1	20.0%

Which technologies does Anovent Pharmaceutical (U.S.), LLC patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

C07K - Peptides 1

B05B - Spraying APPARATUS; Atomising APPARATUS; Nozzles 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 1

Top 6 of 6 technology areas

Where it ranks

Overall rank by patents

#44,735

of 49,997 tracked assignees

Innovation Score

44.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Anovent Pharmaceutical (U.S.), LLC's patent record in context - here's where to go next.

Anovent Pharmaceutical (U.S.), LLC's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #44,735 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Anovent Pharmaceutical (U.S.), LLC against Anhui Maoxin Home Crafts Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.